Cutaneous necrotic loxoscelism. A case report;Loxoscelismo cutáneo necrótico. Informe de un caso

Revista Alergia Mexico

Volumn 58, Issue 3, 2011, Pages 171-176

  Sánchez Olivas, Manuel Anastacio ^a   Valencia Zavala, Martha Patricia ^a   Sánchez Olivas, Jesús Alberto ^a   Sepulveda Velázquez, Guadalupe ^b   Vega Robledo, Gloria ^c  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b Laboratorio de Investigación Química y Farmacológica de Productos Naturales   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Enzyme sphingomyelinase; Mexico; Necrotic arachnidism; Necrotic lesions

Indexed keywords

ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; CLINICAL STUDY; HUMAN; MALE; SKIN NECROSIS; SPIDER BITE; ANIMAL; ARACHNID; ERYTHEMA; NECROSIS; SPIDER;

ANIMALS; ARACHNIDA; ERYTHEMA; HUMANS; NECROSIS; SPIDER BITES; SPIDERS;

EID: 84858221414     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wendell R, Brown P. Recluse Spiders: A review to help guide physicians in nonendemic areas. Southern Med J 2003;96:486-488.
2. Schenone HF. Cuadros tóxicos producidos por mordeduras de araña en Chile: latrodectismo y loxoscelismo. Rev Med Chile 2003;131:437-444.
3. Swanson DL, Vetter R. Bites of brown recluse spiders and suspected necrotic arachnidism. N Engl J Med 2005;352:700-707. (Pubitemid 40239218)
4. Sams H, Heart SB, Long LL, et al. Nineteen documented cases of Loxosceles reclusa envenomation. J Acad Dermatol 2001;48:603-8. (Pubitemid 32249515)
5. Schenone H, Rubio S, Saavedra T, Rojas A. Loxoscelismo en pediatría. Rev Chil Pediatr 2001;72:100-9.
6. Araujo SC, Castanheira P, Alvarenga LM, et al. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein. Toxicon 2003;41:261-267. (Pubitemid 36144163)
7. De Roodt AR, Salomon OD, Lloveras SC, Orduña TA. Envenenamiento por arañas del género Loxosceles. Medicina (B Aires) 2002;62:83-94.
8. Bojan D, Bao Y, Ramos-Cerrillo B, et al. Upregulation of IL-6, IL8, CXCL1, and CXCL2 dominates gene expression in human fibroblast cells exposed to Loxosceles reclusa sphingomyelinase D: Insights into spider venom dermonecrosis. J Invest Dermatol 2007;127:1264-1266. (Pubitemid 46625133)
9. McDade J, Aygun B, Russell E, Ware. Brown recluse spider (loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents. J Pediatr 2010;156:155-157.
10. Zanetti VC, Da Silveira RB, Dreyfuss JL, et al. Morphological and biochemical evidence of blood vessel damage and fibrinogenolysis triggered by brown spider venom. Blood Coagul Fibrin 2002;13:135-48. (Pubitemid 35001677)
11. Parra D, Torres M. Loxoscelismo: una patología vigente. Pediatría al día 2000;16:178-83.
12. Nunnelee JD. Brown recluse spider bites: A case report . J Peri Anesth Nursing 2006;21:12-15. (Pubitemid 43163153)
13. Ashton AC, Rahman MA, Volynski KE. Tetramerisation of α-latrotoxin by divalent cations is responsible for toxin-induced non-vesicular release and contributes to the Ca2+-dependent vesicular exocytosis from synaptosomes. Biochimie 2000;82:453-468. (Pubitemid 30391901)
14. Peterson ME. Brown spider envenomation. Clin Tech Small Anim Pract 2006;21:191-3. (Pubitemid 44909545)
15. 2+-dependent pathways, triggers exocytosis of two pools of synaptic vesicles. J Biol Chem 2001;276:44695-44703.
16. Vetter RS. Arachnids submitted as suspected brown recluse spiders (Araneae: Sicariidae): Loxosceles spiders are virtually restricted to their known distributions but are perceived to exist throughout the United States. J Med Entomol 2005;42:512-21. (Pubitemid 41040451)
17. Veiga SS, da Silveira RB, Dreyfuss JL. Identification of high molecular weight serine-proteases in Loxosceles intermedia (brown spider) venom. Toxicon 2000;38:825-40.
18. Van Den Berg CW, Gonçalves De Andrade RM, Magno FC, et al. Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis. Immunol 2002,107:102-110.
19. Tambourgi DV, Morgan BP, De Andrade RM. Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis. Blood 2000;95:683-91. (Pubitemid 30041687)
20. Paixão-Cavalcante D, Van den Berg CW, Fernandes-Pedrosa MF, et al. Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by loxosceles venom sphingomyelinase D. J Invest Dermatol 2006;126:61-68.
21. Murakami MT, Fernandes-Pedrosa MF, Tambourgi DV, Raghuvir KA. Structural basis for metal-ion coordination and the catalytic mechanism of sphingomyelinases D. J Biol Chem 2005;280:13658-13664. (Pubitemid 40517260)
22. Lee S, Lynch KR. Brown recluse spider (Loxosceles reclusa) venom phospholipase D generates lysophosphatidic acid. Biochem J 2005;391:317-23. (Pubitemid 41532429)
23. De Roodt AR, Estevez-Ramirez J, Litwin J, et al. Toxicity of two north american Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms. Clin Toxicol 2007;45:678-687. (Pubitemid 47407580)
24. Tambourgi DV, Fernandes Pedrosa MF, van den Berg CW, et al. Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands. Mol Immunol 2004;41:831-840. (Pubitemid 38953640)
25. Bennett RG, Vetter RS. An approach to spider bites: erroneous attribution of dermonecrotic lesions to brown recluse and hobo spider bites in Canada. Can Fam Physician 2004;50:1098-1101. (Pubitemid 39172869)
26. Tambourgi DV, De Sousa Da Silva M, Billington SJ. Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases. Immunol 2002;107:93-101.
27. Trevisan-Silva D, Gremski LH, Chaim OM, et al. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles). Biochem 2010;92:21-32.
28. Vassilevski AA, Kozlov SA, Grishin EV. Molecular diversity of spider venom. Biochem 2009;74:1505-34.
29. Isbister GK. Necrotic arachnidism: the mythology of a modern plague. Lancet 2004;364:551-553.
30. Acharya MR, Venitz J, Figg WD, Sparreboom A. Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. Drug Resist Updates 2004;7:195-208. (Pubitemid 39024520)
31. Cowan MJ, Huang X, Yao XL, Shelhamer JH. Tumor necrosis factor alpha stimulation of human clara cell secretory protein production by human airway epithelial cells. Ann New York Acad Sci 2000;923:193-201. (Pubitemid 32050215)
32. Bryant SM, Pittman LM. Dapsone use in Loxosceles reclusa envenomation: is there an indication? Am J Emerg Med 2003;21:89-90. (Pubitemid 36176145)
33. Warner RL, Lewis CS, Beltran L, et al. The role of metalloproteinases in immune complex induced acute lung injury. Am J Pathol 2001;158:2139-2144. (Pubitemid 32545199)
34. Vetter RS. Myths about spider envenomations and necrotic skin lesions. Lancet 2004;364:84-85.
35. Du XY, Sim DS, Lee WH, Zhang Y. Blood cells as targets of snake toxins. Blood Cells Mol Dis 2006;36:414-21. (Pubitemid 43776191)
36. Tavares L, Sousa-e-Silva S, Santoro M, et al. Changes in hematological, hemostatic and biochemical parameters induced experimentally in rabbits by Loxosceles gaucho spider venom Human. Experiment Toxicol 2004;23:477-486. (Pubitemid 39472914)
37. Tambourgi DV, Morgan BP, de Andrade RM, et al. Loxosceles intermedia spider envenomation induces activation of an endogenous metalloproteinase, resulting in cleavage of glycophorins from the erythrocyte surface and facilitating complement-mediated lysis. Blood 2000;95:683-91. (Pubitemid 30041687)
38. De Oliveira K, De Andrade RM, Piazza R, et al. Tambourgi DV. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation. Toxicon 2005;45:421-429. (Pubitemid 40269932)
39. Guilherme P, Fernandes I, Barbaro KC. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. 2005;39:1333-42.
40. Senone H, Rubio S, Saavedra T, Rojas A. Loxoscelismo en pediatría. Región Metropolitana, Rev Chil Pediatr 2001;72:100-109.
41. Chávez-Olórtegui C, Bohórquez K, Alvarenga LM, et al. Sandwich-ELISA detection of venom antigens in envenoming by Phoneutria nigriventer spider. Toxicon 2001;39:909-11. (Pubitemid 32012959)
42. White J, Cardoso JLC, Fan HW. Clinical toxicology of spider bites. In: Meir J, White J. (eds.): Handbook of Clinical Toxicology of Animal Venoms and Poisons. Boca Raton, CRC Press 1995;pp:261-329.
43. Van Meeteren LA, Frederiks F, Giepmans BN, et al. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J Biol Chem 2004;279:10833-10836. (Pubitemid 38401571)
44. Ministério da Saúde. Manual de Diagnóstico e Tratamento de Acidentes por Animais Peconhentos. Ministério da Saúde. Fundacao Nacional de Saúde. Brasilia. 1999.